Keyphrases
Systematic Literature Review
100%
Randomized Clinical Trial
100%
Protective Effect
100%
HPV Vaccine
100%
HPV31
100%
Cross-protection
100%
Cross-protective
100%
Vaccine Effectiveness
50%
HPV-45
50%
Persistent Infection
33%
Randomized Controlled Trial
33%
Quadrivalent Vaccine
33%
HPV Types
33%
HPV Prevalence
33%
Bivalent Vaccine
33%
Embase
16%
PubMed
16%
Confidence Interval
16%
Statistical Significance
16%
Existing Data
16%
Type-specific
16%
Protective Efficacy
16%
Nave
16%
Trial Data
16%
Long-term Durability
16%
Fully Vaccinated
16%
Genital HPV
16%
CIN2+
16%
Extended Follow-up
16%
Bivalent HPV Vaccine
16%
Quadrivalent HPV Vaccine
16%
Cervical Infection
16%
Non-vaccine Types
16%
Genital Lesions
16%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Human Papillomavirus Type 31
100%
Observational Study
83%
Randomized Controlled Trial
83%
Vaccine Efficacy
50%
Human Papillomavirus Type 45
50%
Persistent Infection
33%
Diseases
16%
Prevalence
16%
Infection
16%